Amicogen Revenue

In the year 2025, Amicogen had annual revenue of 41.98B KRW, down -75.82%. Amicogen had revenue of 10.87B in the quarter ending December 31, 2025, a decrease of -80.88%.

Revenue

41.98B

Revenue Growth

-75.82%

P/S Ratio

3.17

Revenue / Employee

177.89M

Employees

236

Market Cap

133.16B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	41.98B	-131.62B	-75.82%
Dec 31, 2024	173.60B	13.70B	8.57%
Dec 31, 2023	159.90B	15.61B	10.82%
Dec 31, 2022	144.30B	19.41B	15.55%
Dec 31, 2021	124.88B	9.02B	7.79%
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
iNtRON Biotechnology	5.74B
Oncocross	370.46M
CG Invites	27.39B
IMB Dx	5.33B
ENCell	5.26B
Vaxcell-Bio Therapeutics	1.90B
Macrogen	195.27B
MedPacto	3.90B

Revenue Rankings